Final Long-Term Reporting from a Randomized Controlled IDE Trial for Lumbar Artificial Discs in Single-Level Degenerative Disc Disease: 7-Year Results
The International Journal of Spine Surgery2021Vol. 15(4), pp. 612–632
Citations Over TimeTop 17% of 2021 papers
Kris E. Radcliff, Jack E. Zigler, Ernest Braxton, Glen Buttermann, Dom Coric, Peter B. Derman, Rolando García, Anton Jorgensen, Nicole Ferko, Aaron Situ, James J. Yue
Abstract
1.
Related Papers
- → A Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemptions Study of Lumbar Total Disc Replacement With the CHARITÉ™ Artificial Disc Versus Lumbar Fusion(2005)582 cited
- → Prospective, Randomized Trial of Metal-on-Metal Artificial Lumbar Disc Replacement(2008)117 cited
- → Neurological complications of lumbar artificial disc replacement and comparison of clinical results with those related to lumbar arthrodesis in the literature: results of a multicenter, prospective, randomized investigational device exemption study of Charité intervertebral disc(2004)160 cited
- → Complications and Rates of Subsequent Lumbar Surgery Following Lumbar Total Disc Arthroplasty and Lumbar Fusion(2016)40 cited
- → Lumbar disc arthroplasty versus anterior lumbar interbody fusion: 5-year outcomes for patients in the Maverick disc investigational device exemption study(2019)29 cited